Plerixafor was recently approved by the US Food and Drug Administration (FDA) and the European Medicines Evaluation Agency (EMEA) to enhance stem cell mobilization for autologous transplant in ...

Engraftment of HSPC mobilized using plerixafor plus G-CSF is comparable with engraftment of HSPC mobilized with G-CSF alone. 11,12 Interestingly, there is emerging data indicating that plerixafor may ...

Use of granulocyte colony-stimulating factor plus plerixafor for stem cell mobilization is cost-effective in pretreated patients with non-Hodgkin lymphoma. Autologous peripheral stem cell ...

June 21, 2012 (Amsterdam, the Netherlands) — The mobilization of stem cells for transplantation with plerixafor (Mozobil, Genzyme) in patients with lymphoma and myeloma improved the yield of cells ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Plerixafor Injection, a generic equivalent to Mozobil ®, available immediately in the United States in a 24 mg per ...

WHIM syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis), a primary immunodeficiency disorder involving panleukopenia, is caused by autosomal dominant gain-of-function mutations in ...

Improved outcomes with maintenance therapy after salvage autologous hematopoietic cell transplantation (AHCT) in multiple myeloma: A CIBMTR study. This is an ASCO Meeting Abstract from the 2021 ASCO ...

Discover comprehensive details about Plerixafor Injection, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

New FDA approved drug, plerixafor, which is a CRCX4 inhibitor, reduces resistance to anti-angiogenesis treatment by blocking VEGF-signaling pathway. A potential drug that improves efficacy of ...

December 13, 2007 (Atlanta) — Stem cell transplantation is a standard of care in several hematologic diseases, but many patients are unable to mobilize a sufficient number of cells for transplantation ...

Credit: Getty Images. Researchers sought to determine whether the combination of MGTA-145 and plerixafor would be effective for HSC mobilization for autologous transplant in patients with multiple ...

This trial is no longer recruiting patients. We hope to add results when they are available. This trial is looking at a drug called plerixafor which can help to move stem cells from your bone marrow ...